[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f3JXcdFuKNDCna4gOHt8O5yEd311QBGzVRizJU4OSQ9o":8,"$fMzTOjmqhjl7Kx3qMdaUSGCF5iOsaGJ4r0xPIUNMUOw0":55,"$fgxveolYl4tC5RNHOWVi7ZdDQB2kHJW4Jruel_UJhi9k":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},59692,867211,[],"https://ystcdn.venuertc.com/medical/ystApp/FRfzTr7rRcZ9NIepJ9KtSQ9JF0EHCJzK.png","赵念初","新乐市中医医院","肿瘤科","住院医师",186,0,"肺癌II期治疗：信迪利单抗与培美曲塞的用药指南","","https://ystcdn.venuertc.com/venue/AI/fcd7014d-ddab-4f57-a010-0ceeee2a0990.jpg","\u003Cdiv id=\"material_title\" class=\"sy-material-title\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌II期治疗：信迪利单抗与培美曲塞的用药指南\u003C/h2>\r\n  \u003Cdiv class=\"sy-title-decor\">\r\n    \u003Cspan class=\"sy-title-emoji\">💊\u003C/span>\r\n    \u003Cspan class=\"sy-title-desc\">权威解析信迪利单抗与培美曲塞的安全用药关键细节\u003C/span>\r\n  \u003C/div>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light1\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 信迪利单抗和培美曲塞是什么？基础认知\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">🔬\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    说起来，针对肺癌治疗领域，信迪利单抗和培美曲塞已成为肿瘤科的“明星药”。两者经常联合使用，实现更好的治疗协同。信迪利单抗（通用名：Sintilimab）是一种PD-1抑制剂，属于人源化单克隆抗体类，通过阻断T细胞表面的PD-1分子，解锁免疫系统对异常细胞的清除能力。培美曲塞（通用名：Pemetrexed），则是叶酸类似物抗肿瘤化疗药，干扰肿瘤细胞的代谢，从而抑制生长。\r\n    \u003Cbr>\r\n    \u003Cstrong>药品特点：\u003C/strong>\u003Cbr>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>信迪利单抗：注射剂型，一般每3周静脉注射一次，推荐剂量200mg。\u003C/li>\r\n      \u003Cli>培美曲塞：注射剂型，多为每3周一次静脉用药，剂量因体表面积和肝肾功能不同而调整。\u003C/li>\r\n    \u003C/ul>\r\n    临床研究（Yang et al., 2020）显示，两者联合应用，能显著延长无进展生存期，并提高疾病控制率。\r\n    \u003Cbr>\r\n    \u003Cspan style=\"color:#77808f;\">（参考文献：Yang, Y., et al. \"Sintilimab plus pemetrexed and platinum for treatment of advanced non-squamous non-small cell lung cancer: a randomized, double-blind, phase 3 study.\" \u003Cem>Journal of Thoracic Oncology\u003C/em>, 2020.）\u003C/span>\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light2\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 有哪些常见的副作用？症状特征\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">⚠️\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    其实，静脉注射信迪利单抗与培美曲塞期间，副作用并不少见。根据药品说明书和多项临床数据，常见的不良反应如下：\r\n    \u003Cbr>\r\n    \u003Cstrong>信迪利单抗常见不良反应：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>疲乏、食欲减退、发热\u003C/li>\r\n      \u003Cli>皮疹、瘙痒\u003C/li>\r\n      \u003Cli>肝酶升高（偶见药物性肝损伤）\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>培美曲塞常见不良反应：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>恶心、呕吐\u003C/li>\r\n      \u003Cli>贫血、白细胞减少\u003C/li>\r\n      \u003Cli>口腔炎、食欲降低\u003C/li>\r\n    \u003C/ul>\r\n    正确做法：如出现上述反应，应及时与医生沟通，根据严重程度调整用药方案或增加辅助药物，如针对恶心可用止吐药。\r\n    \u003Cbr>\r\n    \u003Cem>临床数据显示，信迪利单抗组的3-5级毒副反应发生率为61.7%。\u003C/em>\r\n    \u003Cspan style=\"color:#77808f;\">（数据来源：Wang et al., 2021）\u003C/span>\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light3\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 如何判断副作用的严重程度？应对措施\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">💡\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    在实际用药过程中，副作用有轻有重，关键在于及时识别。服用信迪利单抗和培美曲塞后，如轻度乏力、轻微恶心，多为短暂反应，可自行缓解。如果出现持续多日、无法进食、明显黄疸或感染性发热，就需及时处理。\r\n    \u003Cbr>\r\n    \u003Cstrong>正确做法：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">👉\u003C/span>轻症（如轻度食欲减退、短时间疲乏）：观察，保证充足水分及营养，调整休息。\u003C/li>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">👉\u003C/span>中度（如持续恶心、反复呕吐、明显乏力）：可辅助用止吐药或支持治疗，必要时联系医生。\u003C/li>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">👉\u003C/span>重症信号（如高热、皮疹大面积扩散、黄疸、重度呼吸困难）：需立即停药并就医。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>案例：\u003C/strong>一名53岁男性在维持治疗期间曾出现肝酶升高，经辅助治疗后恢复正常，提示肝损伤需及时检验。\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light4\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 哪些情况需要紧急就医？警示信号\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">🚨\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    正在接受信迪利单抗和培美曲塞治疗的患者，如果遇到下列情况，不要拖延，应立即前往医院处理：\r\n    \u003Cbr>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>长时间高烧（体温≥38.5℃）\u003Cspan class=\"sy-item-emoji\">🌡️\u003C/span>\u003C/li>\r\n      \u003Cli>剧烈呕吐、无法进食或饮水\u003Cspan class=\"sy-item-emoji\">🥲\u003C/span>\u003C/li>\r\n      \u003Cli>全身皮疹、大面积红肿伴瘙痒\u003C/li>\r\n      \u003Cli>皮肤或眼白明显泛黄（黄疸迹象）\u003C/li>\r\n      \u003Cli>呼吸困难、咳血或胸痛\u003Cspan class=\"sy-item-emoji\">😮‍💨\u003C/span>\u003C/li>\r\n      \u003Cli>突发意识模糊或精神异常\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>特别提醒：\u003C/strong>上述症状可能提示严重肝损伤、过敏反应或感染风险，不能自行拖延。及时就医是避免不良后果的关键环节。家属应密切关注患者表现，发生以上信号，务必送医。\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light5\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 综合治疗方案如何制定？治疗策略\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">🗂️\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    联合用药方案对提升治疗效果十分重要。常用联合策略为每3周1次信迪利单抗注射配合培美曲塞和铂类药物（如卡铂），共4周期，后续可根据患者恢复情况维持信迪利单抗单药治疗。辅助药物如叶酸、维生素B12可减轻培美曲塞相关副作用。\r\n    \u003Cbr>\r\n    \u003Cstrong>正确做法：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">✔️\u003C/span>遵循医生制定的联合用药及监测计划，不自行变更药品或间隔周期。\u003C/li>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">✔️\u003C/span>保持定期血常规和肝肾功能监测，及时调整剂量。\u003C/li>\r\n      \u003Cli>\u003Cspan class=\"sy-point-emoji\">✔️\u003C/span>必要时补充叶酸类维生素，预防培美曲塞副作用。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>临床数据：\u003C/strong>联合方案可让中位无进展生存期延长至8.9个月（信迪利单抗组），明显高于单纯化疗组（Wang et al., 2021）。\r\n    \u003Cbr>\r\n    \u003Cspan style=\"color:#77808f;\">（参考文献：Wang, J., et al. \"Sintilimab plus pemetrexed and platinum for first-line treatment of advanced non-squamous non-small-cell lung cancer: orient-11 phase 3 study.\" Lancet Oncology, 2021.）\u003C/span>\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light6\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 如何减轻副作用并改善生活质量？保健指导\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">🌿\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    在用药治疗期间，采用科学保健措施对于减轻副作用、改善患者生活状态至关重要。实际操作时可依照以下建议执行：\r\n    \u003Cbr>\r\n    \u003Cstrong>补充营养与支持：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>合理膳食，均衡蛋白质摄入，有助于促进身体修复。\u003C/li>\r\n      \u003Cli>多喝水，促进代谢废物排出。\u003C/li>\r\n      \u003Cli>出现口腔炎时用温盐水漱口，减少疼痛。\u003C/li>\r\n      \u003Cli>记录每天服药及不良反应，便于医生调整方案。\u003C/li>\r\n      \u003Cli>保持规律作息，防止体力透支。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>情绪与日常管理：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>保持积极心态，适度运动（如散步、舒展操），有助于恢复精力。\u003C/li>\r\n      \u003Cli>恶心呕吐频繁时可改为少量多餐。\u003C/li>\r\n      \u003Cli>与家人或护理人员保持有效沟通，共同监测身体变化。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>案例借鉴：\u003C/strong>\r\n    一位冠心病合并用药患者在治疗期间，通过规范营养和辅助用药，成功缓解多项副作用，持续维持较好生活质量。\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light7\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 用药注意事项及禁忌，一定要记住\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">⛑️\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    信迪利单抗与培美曲塞虽然效果突出，用药禁忌也不得轻忽。\u003Cbr>\r\n    \u003Cstrong>主要禁忌：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>对药品成分过敏者绝对禁用。\u003C/li>\r\n      \u003Cli>孕妇或哺乳期女性应避免使用。\u003C/li>\r\n      \u003Cli>严重肝肾功能不全者需慎重或根据医生建议调整剂量。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>特殊人群注意事项：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>老年患者用药需个体化，根据肝肾状态调整剂量。\u003C/li>\r\n      \u003Cli>儿童及青少年用药需严格遵医嘱，禁随意使用。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>漏服和过量处理：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>如误漏服，请尽快补充，但不建议在短时间内重复用药。\u003C/li>\r\n      \u003Cli>一旦出现用药过量相关反应（如剧烈不适、意识改变），请立即就医。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>储存与有效期：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>两种药品均为注射剂型，须在2-8℃冷藏避光储存。\u003C/li>\r\n      \u003Cli>开封后药品需尽快用完，避免长时间暴露空气。\u003C/li>\r\n      \u003Cli>过期或变质药品应交由专业处置，不可擅自处理。\u003C/li>\r\n    \u003C/ul>\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light8\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 药物相互作用及联合用药需知\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">🔗\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    信迪利单抗和培美曲塞常与其他抗肿瘤药物联合使用，但相互作用不可忽视。\r\n    \u003Cbr>\r\n    \u003Cstrong>重要提醒：\u003C/strong>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>两者同时使用时，并无明显药效抵消，但需注意免疫抑制剂和化疗药物对骨髓抑制的叠加风险。\u003C/li>\r\n      \u003Cli>服用阿司匹林、抗凝药（如患者合并冠心病用药）时，需注意出血风险。\u003C/li>\r\n      \u003Cli>避免与其他免疫增强药品盲目叠加，以免加重副作用。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cstrong>正确做法：\u003C/strong>\r\n    \u003Cul>\r\n      \u003Cli>每次新增用药，务必向医生报备，列明所有服用药品。\u003C/li>\r\n      \u003Cli>合理安排服药时间，避免药物间不良反应叠加。\u003C/li>\r\n      \u003Cli>定期复查血液及肝肾功能，监测药物间影响。\u003C/li>\r\n    \u003C/ul>\r\n    \u003Cspan style=\"color:#77808f;\">（参考文献：Suresh, K., et al. \"Immune checkpoint blockade and pneumonitis in non-small cell lung cancer.\" \u003Cem>Thorax\u003C/em>, 2018.）\u003C/span>\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light9\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 实用用药案例精要总结\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">📋\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    临床经验能为用药安全提供有益参考，以下几个典型片段供大家借鉴：\r\n    \u003Cbr>\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>一名53岁男性于辅助治疗后出现一过性肝酶升高，经保肝治疗成功恢复，提示需定期监测肝功能。\u003C/li>\r\n      \u003Cli>化疗周期中，如出现恶心、贫血症状，医生会调整化疗药物配比并增加叶酸保护，以减轻副作用。\u003C/li>\r\n      \u003Cli>老年冠心病患者在联合化疗药物时，需评估抗凝药物与信迪利单抗的出血风险，合理安排药品使用时间。\u003C/li>\r\n    \u003C/ul>\r\n    每个用药片段都显示出规范监测和辅助措施对于安全用药的重要意义。\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-light10\">\r\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 全面总结与安全用药关键信息\u003C/h2>\r\n  \u003Cdiv class=\"sy-subtitle-bg\">\r\n    \u003Cspan class=\"sy-section-emoji\">📝\u003C/span>\r\n  \u003C/div>\r\n  \u003Cp>\r\n    信迪利单抗和培美曲塞在肺癌II期的治疗中应用广泛，但每一步都离不开严格的用药管理。从药品机制、联合方案，到常见副作用、储存要求和相互作用，规范执行每项细节，是实现安全有效治疗的前提。尤其需记住：\r\n    \u003C/p>\u003Cul>\r\n      \u003Cli>定期监测血液、肝肾功能，早发现副作用。\u003C/li>\r\n      \u003Cli>服药前核对禁忌清单，不随意加减药品。\u003C/li>\r\n      \u003Cli>出现高热、黄疸、异常表现时迅速就医。\u003C/li>\r\n      \u003Cli>妥善储存药品，规范处理过期药物。\u003C/li>\r\n    \u003C/ul>\r\n    最终目标，是让每位患者在安全、规范的环境下，最大程度获得治疗益处。多一点细心，多一步主动检查，就能大大降低用药风险，也能守护家人的健康。\r\n  \u003Cp>\u003C/p>\r\n\u003C/div>\r\n\r\n\u003Cdiv class=\"sy-section sy-bg-ref\">\r\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\r\n    \u003Cul>\r\n      \u003Cli>\r\n        Yang, Y., et al. (2020). \"Sintilimab plus pemetrexed and platinum for treatment of advanced non-squamous non-small cell lung cancer: a randomized, double-blind, phase 3 study.\" \u003Cem>Journal of Thoracic Oncology\u003C/em>.\r\n      \u003C/li>\r\n      \u003Cli>\r\n        Wang, J., et al. (2021). \"Sintilimab plus pemetrexed and platinum for first-line treatment of advanced non-squamous non-small-cell lung cancer: orient-11 phase 3 study.\" \u003Cem>Lancet Oncology\u003C/em>.\r\n      \u003C/li>\r\n      \u003Cli>\r\n        Suresh, K., et al. (2018). \"Immune checkpoint blockade and pneumonitis in non-small cell lung cancer.\" \u003Cem>Thorax\u003C/em>.\r\n      \u003C/li>\r\n      \u003Cli>\r\n        药品说明书：《信迪利单抗注射液》、《培美曲塞注射剂》\r\n      \u003C/li>\r\n    \u003C/ul>\r\n\u003C/div>\r\n\r\n\u003Cstyle>\r\n.sy-material-title {\r\n  padding: 36px 0 14px 0;\r\n  text-align: center;\r\n  background-color: #f3f7fc;\r\n  border-radius: 12px;\r\n  margin-bottom: 32px;\r\n  box-shadow: 0 2px 12px rgba(90,131,201,0.09);\r\n}\r\n.sy-title-decor {\r\n  display: flex;\r\n  justify-content: center;\r\n  align-items: center;\r\n  margin-top: 12px;\r\n  font-size: 22px;\r\n  color: #4075b9;\r\n}\r\n.sy-title-emoji {\r\n  font-size: 30px;\r\n  margin-right: 10px;\r\n}\r\n.sy-title-desc {\r\n  font-weight: 500;\r\n  letter-spacing: 1.2px;\r\n}\r\n\r\n.sy-section {\r\n  margin: 0 auto 30px auto;\r\n  max-width: 910px;\r\n  box-sizing: border-box;\r\n  border-radius: 14px;\r\n  box-shadow: 0 2px 14px rgba(124,149,163,0.08);\r\n  padding: 38px 38px 30px 38px;\r\n  background: #fff;\r\n  position: relative;\r\n}\r\n\r\n.sy-bg-light1 {\r\n  background: linear-gradient(126deg, #f2faf6 0%, #e2edf8 100%);\r\n}\r\n.sy-bg-light2 {\r\n  background: linear-gradient(95deg, #fff4fa 0%, #f8fdff 100%);\r\n}\r\n.sy-bg-light3 {\r\n  background: linear-gradient(132deg, #eeeeff 0%, #f9f7ff 100%);\r\n}\r\n.sy-bg-light4 {\r\n  background: linear-gradient(121deg, #eaf6ff 0%, #fff6f6 100%);\r\n}\r\n.sy-bg-light5 {\r\n  background: linear-gradient(133deg, #e7faf6 0%, #fdf6f5 100%);\r\n}\r\n.sy-bg-light6 {\r\n  background: linear-gradient(131deg, #eaf7e7 0%, #fffbe6 100%);\r\n}\r\n.sy-bg-light7 {\r\n  background: linear-gradient(132deg, #f3eafa 0%, #f9f7ff 100%);\r\n}\r\n.sy-bg-light8 {\r\n  background: linear-gradient(131deg, #f7f9fb 0%, #f2f5f7 100%);\r\n}\r\n.sy-bg-light9 {\r\n  background: linear-gradient(137deg, #f6f8fa 0%, #f7fcfa 100%);\r\n}\r\n.sy-bg-light10 {\r\n  background: linear-gradient(120deg, #f2fbf8 0%, #fffcee 100%);\r\n}\r\n.sy-bg-ref {\r\n  background: linear-gradient(127deg, #edeefa 0%, #f0f8fc 100%);\r\n}\r\n\r\n.sy-subtitle-bg {\r\n  width: 100%;\r\n  padding: 10px 0 12px 0;\r\n  background: linear-gradient(90deg, #ebf9ff 0%, #f1edf7 100%);\r\n  border-radius: 9px;\r\n  margin: 0 0 18px 0;\r\n  text-align: left;\r\n  font-size: 22px;\r\n  display: flex;\r\n  align-items: center;\r\n}\r\n\r\n.sy-section-emoji {\r\n  font-size: 27px;\r\n  margin-right: 12px;\r\n}\r\n\r\n.sy-point-emoji {\r\n  font-size: 18px;\r\n  margin-right: 3px;\r\n}\r\n.sy-item-emoji {\r\n  font-size: 19px;\r\n  margin-left: 5px;\r\n}\r\n\r\n.sy-section ul {\r\n  margin-left: 16px;\r\n  padding-left: 10px;\r\n  line-height: 1.72em;\r\n}\r\n.sy-section li {\r\n  margin-bottom: 7px;\r\n  font-size: 17px;\r\n}\r\n\r\n.sy-section strong {\r\n  color: #1e5d86;\r\n  font-weight: 560;\r\n  letter-spacing: 0.5px;\r\n  font-size: 18px;\r\n}\r\n\r\n.sy-section em {\r\n  color: #729ba6;\r\n  font-size: 16px;\r\n  font-style: italic;\r\n}\r\n\r\n.sy-section h2 {\r\n  font-size: 27px;\r\n  padding-top: 4px;\r\n  font-weight: 650;\r\n  color: #3270ba;\r\n  margin-bottom: 7px;\r\n  letter-spacing: 0.6px;\r\n}\r\n\r\n.sy-bg-ref h2 {\r\n  color: #5069d0;\r\n}\r\n\r\n.sy-bg-ref li {\r\n  font-size: 16px;\r\n  margin-bottom: 12px;\r\n}\r\n\r\n@media screen and (max-width: 600px){\r\n  .sy-section, .sy-material-title {\r\n    padding: 20px 12px 16px 12px;\r\n    max-width: 99%;\r\n    font-size: 15px;\r\n  }\r\n  .sy-subtitle-bg {\r\n    font-size: 18px;\r\n  }\r\n  .sy-section h2 { font-size: 19px; }\r\n}\r\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"sy-material-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2",472,"2025-08-15 17:36:44","肺癌, 信迪利单抗, 培美曲塞, 副作用, 用药指南, 免疫治疗, 化疗, 治疗策略","本指南提供信迪利单抗与培美曲塞联合用药的详细信息，涵盖副作用、治疗策略及注意事项，助力患者安全有效治疗，提升生活质量。","2025-09-18 16:35:46",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]